Compare Trinitan Metals and Minerals Tbk. (PURE) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Trinitan Metals and Minerals Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Trinitan Metals and Minerals Tbk. trades at Rp51 (market cap 70.13B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| PURE | SCPI | |
|---|---|---|
Market Cap | 70.13B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Trinitan Metals and Minerals Tbk.
PT Trinitan Metals and Minerals Tbk (the Entity) was established based on Notarial Deed No. 14, dated June 9, 2009, of Petrus Suandi Halim, S.H., notary in Jakarta. The Entity started its commercial operations in 2011. The Entity belong to group of companies owned by Trinitan Group. The Entity's parent entity is PT Trinitan Resourcetama Indonesia.
Read more on PURE →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
